HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum antibodies in patients with alveolar echinococcosis before and after therapy.

Abstract
Thirty-three patients with alveolar echinococcosis treated by surgery or with mebendazole were observed up to six years. Of three immunoassays (IgG ELISA, complement fixation, indirect haemagglutination) correlation with the clinical course was achieved by IgG ELISA only. Serum antibody levels tended to increase during the first year and decreased during the second year after therapy had been started, Long persisting antibody was most sensitively indicated by indirect haemagglutination.
AuthorsJ Knobloch, H Biedermann, E Mannweiler
JournalTropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ) (Trop Med Parasitol) Vol. 36 Issue 3 Pg. 155-6 (Sep 1985) ISSN: 0177-2392 [Print] Germany
PMID4081546 (Publication Type: Journal Article)
Chemical References
  • Antibodies
  • Thymol
  • Mebendazole
Topics
  • Antibodies (analysis)
  • Complement Fixation Tests
  • Echinococcosis (drug therapy, immunology, surgery)
  • Echinococcosis, Hepatic (drug therapy, immunology, surgery)
  • Echinococcosis, Pulmonary (drug therapy, immunology, surgery)
  • Echinococcus (immunology)
  • Enzyme-Linked Immunosorbent Assay
  • Hemagglutination Tests
  • Humans
  • Mebendazole (therapeutic use)
  • Thymol (therapeutic use)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: